Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,835 | -10,295 | -5,670 | -21,900 | -17,297 |
| Depreciation Amortization | 327 | 216 | 108 | 420 | 316 |
| Other Working Capital | -721 | -868 | -664 | -1,277 | -454 |
| Other Operating Activity | 870 | 582 | 372 | 1,295 | 984 |
| Operating Cash Flow | $-15,359 | $-10,365 | $-5,854 | $-21,462 | $-16,451 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | N/A | N/A | -64 | -59 |
| Investing Cash Flow | $-8 | $N/A | $N/A | $-64 | $-59 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -401 | -266 | -132 | -322 | -278 |
| Common Stock Issued | 54,748 | 54,839 | 2,674 | 17,436 | 17,436 |
| Other Financing Activity | 0 | 4 | 0 | 0 | 0 |
| Financing Cash Flow | $54,347 | $54,577 | $2,542 | $17,114 | $17,158 |
| Beginning Cash Position | 9,693 | 9,693 | 9,693 | 14,105 | 14,104 |
| End Cash Position | 48,673 | 53,905 | 6,381 | 9,693 | 14,752 |
| Net Cash Flow | $38,980 | $44,212 | $-3,312 | $-4,412 | $648 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,359 | -10,365 | -5,854 | -21,462 | -16,451 |
| Capital Expenditure | -8 | 0 | 0 | -64 | -59 |
| Free Cash Flow | -15,367 | -10,365 | -5,854 | -21,526 | -16,510 |